SARS-CoV-2 Testing and Positivity among Persons with and Without HIV in 6 US Cohorts
Public DepositedAdd to collection
You do not have access to any existing collections. You may create a new collection.
Downloadable Content
Download PDFCitation
MLA
Althoff, K.N, et al. Sars-cov-2 Testing and Positivity Among Persons with and Without Hiv In 6 Us Cohorts. Lippincott Williams and Wilkins, 2022. https://doi.org/10.17615/b066-4975APA
Althoff, K., Park, L., Mc Ginnis, K., Gordon, K., Justice, A., Leyden, W., Silverberg, M., Skarbinski, J., Jefferson, C., Horberg, M., Certa, J., Napravnik, S., Edwards, J., Westreich, D., Bastarache, L., Gangireddy, S., Benning, L., D'souza, G., & Williams, C. (2022). SARS-CoV-2 Testing and Positivity among Persons with and Without HIV in 6 US Cohorts. Lippincott Williams and Wilkins. https://doi.org/10.17615/b066-4975Chicago
Althoff, K.N., L.S Park, K.A Mc Ginnis, K.S Gordon, A.C Justice, W Leyden, M.J Silverberg et al. 2022. Sars-Cov-2 Testing and Positivity Among Persons with and Without Hiv In 6 Us Cohorts. Lippincott Williams and Wilkins. https://doi.org/10.17615/b066-4975- Creator
-
Althoff, K.N.
- Other Affiliation: Johns Hopkins University
-
Park, L.S.
- Other Affiliation: Stanford University School of Medicine
-
McGinnis, K.A.
- Other Affiliation: Va Connecticut Healthcare
-
Gordon, K.S.
- Other Affiliation: Va Connecticut Healthcare
-
Justice, A.C.
- Other Affiliation: Va Connecticut Healthcare
-
Leyden, W.
- Other Affiliation: Kaiser Permanente Northern California
-
Silverberg, M.J.
- Other Affiliation: Kaiser Permanente Northern California
-
Skarbinski, J.
- Other Affiliation: Kaiser Permanente Northern California
-
Jefferson, C.
- Other Affiliation: Kaiser Permanente Mid-Atlantic Permanente Research Institute
-
Horberg, M.
- Other Affiliation: Kaiser Permanente Mid-Atlantic Permanente Research Institute
-
Certa, J.
- Other Affiliation: Kaiser Permanente Mid-Atlantic Permanente Research Institute
-
Napravnik, S.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Edwards, J.K.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Westreich, D.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Bastarache, L.
- Other Affiliation: Vanderbilt University Medical Center
-
Gangireddy, S.
- Other Affiliation: Vanderbilt University Medical Center
-
Benning, L.
- Other Affiliation: Johns Hopkins Bloomberg School of Public Health
-
D'Souza, G.
- Other Affiliation: Johns Hopkins Bloomberg School of Public Health
-
Williams, C.
- Other Affiliation: National Institute of Allergy and Infectious Diseases
- Abstract
- Background:It is not definitively known if persons with HIV (PWH) are more likely to be SARS-CoV-2 tested or test positive than persons without HIV (PWoH). We describe SARS-CoV-2 testing and positivity in 6 large geographically and demographically diverse cohorts of PWH and PWoH in the United States.Setting:The Corona Infectious Virus Epidemiology Team comprises 5 clinical cohorts within a health system (Kaiser Permanente Northern California, Oakland, CA; Kaiser Permanente Mid-Atlantic States, Rockville, MD; University of North Carolina Health, Chapel Hill, NC; Vanderbilt University Medical Center, Nashville, TN; and Veterans Aging Cohort Study) and 1 interval cohort (Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort Study).Methods:We calculated the proportion of patients SARS-CoV-2 tested and the test positivity proportion by HIV status from March 1 to December 31, 2020.Results:The cohorts ranged in size from 1675 to 31,304 PWH and 1430 to 3,742,604 PWoH. The proportion of PWH who were tested for SARS-CoV-2 (19.6%-40.5% across sites) was significantly higher than PWoH (14.8%-29.4%) in the clinical cohorts. However, among those tested, the proportion of patients with positive SARS-CoV-2 tests was comparable by HIV status; the difference in proportion of SARS-CoV-2 positivity ranged from 4.7% lower to 1.4% higher.Conclusions:Although PWH had higher testing proportions compared with PWoH, we did not find evidence of increased positivity in 6 large, diverse populations across the United States. Ongoing monitoring of testing, positivity, and COVID-19-related outcomes in PWH are needed, given availability, response, and durability of COVID-19 vaccines; emergence of SARS-CoV-2 variants; and latest therapeutic options.
- Date of publication
- 2022
- Keyword
- DOI
- Identifier
- Resource type
- Article
- Journal title
- Journal of Acquired Immune Deficiency Syndromes
- Journal volume
- 90
- Journal issue
- 3
- Page start
- 249
- Page end
- 255
- Language
- English
- Funder
- U.S. Department of Veterans Affairs, VA
- University of North Carolina, UNC: P30-AI050410, U01-AA020790, U24-AA020794, U24-AA022001, UL1-TR002489
- Gilead Sciences
- National Institute of Allergy and Infectious Diseases, NIAID: U01-AI069918
- ISSN
- 1525-4135
- Publisher
- Lippincott Williams and Wilkins
Relations
- Parents:
- In Collection:
This work has no parents.
Items
Thumbnail | Title | Date Uploaded | Visibility | Actions |
---|---|---|---|---|
sars_cov_2_testing_and_positivity_among_persons.1.pdf | 2023-08-23 | Public | Download |